Athenex, Inc. (United States) has no DMF, CEP or site registration linked in our records. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Athenex, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/athenex-inc

Overview

Athenex, Inc. is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of cancer. The company's mission is to improve the lives of cancer patients by creating more effective, safer, and tolerable treatments. Athenex leverages its global infrastructure to deliver promising therapies through its robust R&D pipeline and strategic partnerships.

Therapeutic areas

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832019-07-11

    Deviations from laboratory control requirements

For suppliers

Is this Athenex, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.